• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BNO
Click for more information
5.26% 20.0¢

BIONOMICS LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
BNO
H.C Wainwright report Val 75c 		27/03/19 37 13K
27/03/19 Last post  windshift Comments Created with Sketch.  37  Views Created with Sketch.  13K 
BNO
Technicals looking sick 		27/03/19 11 2.0K
27/03/19 Last post  Baseless Comments Created with Sketch.  11  Views Created with Sketch.  2.0K 
BNO
Ann: Executive Chairman Extension of Appointment 		15/03/19 0 882
15/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  882 
BNO
Ann: S&P DJI Announces March 2019 Quarterly Rebalance 		15/03/19 6 3.9K
15/03/19 Last post  AJD007 Comments Created with Sketch.  6  Views Created with Sketch.  3.9K 
BNO
Could this be a $2 stock? 		04/03/19 0 893
04/03/19 Last post  venuc123 Comments Created with Sketch.  0  Views Created with Sketch.  893 
BNO
Bionomics cash issues remain 		24/02/19 9 4.2K
24/02/19 Last post  pigman2 Comments Created with Sketch.  9  Views Created with Sketch.  4.2K 
BNO
So much for continuous disclosure....... 		19/02/19 16 6.4K
19/02/19 Last post  windshift Comments Created with Sketch.  16  Views Created with Sketch.  6.4K 
BNO
Ann: Further Analysis of Phase 2 PTSD Trial Results Presentation 		19/02/19 16 7.5K
19/02/19 Last post  windshift Comments Created with Sketch.  16  Views Created with Sketch.  7.5K 

See All Discussions arrow Created with Sketch.

Top Stories

ACCC seeks Olam divestments before it can buy Namoi Cotton

Australia's market regulator the ACCC has expressed further concerns about the potential takeover of Namoi Cotton by Olam Agri.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
The market's shrugged at China's stimulus measures all year. Why is this one different? If you've been following the Chinese economy this year, you'd know that the country has been trying to stimulate all year.
HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico? De Grey Mining on Friday denied reports that it's received a takeover offer from Canada-based Agnico Eagle.
Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop What HotCopper users were watching; China outshines USA's Fed cut; Oz inflation CPI tracks downwards & more!
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.